A Turkish SME+University Consortium Seeks European Partners for AI‑Enabled Multimodal Biomarkers for Cardiometabolic, Neurodegenerative, and Respiratory Disease Monitoring (HORIZON‑HLTH‑2027‑02‑TOOL‑01 )
A Turkish SME consortium is preparing a Horizon Europe proposal to develop and validate AI‑based predictive biomarkers of disease progression and treatment response for chronic non‑communicable diseases (NCDs) using multimodal biomarkers and complementary digital health data. We seek European clinical and technology partners to provide longitudinal cohorts (Parkinson’s disease and COPD), wearable sensor integration, health‑technology assessment (HTA), and patient engagement expertise.